{"id":"https://openalex.org/W2115147648","doi":null,"title":"Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension.","display_name":"Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension.","alternate_titles":[],"publication_year":2005,"publication_date":"2005-06-01","ids":{"openalex":"https://openalex.org/W2115147648","mag":"2115147648","pmid":"https://pubmed.ncbi.nlm.nih.gov/15970067","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1472760"},"language":"en","primary_location":{"id":"pmh:oai:europepmc.org:263210","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1472760","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"parent_works":[],"lineage":["https://openalex.org/W2115147648"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC1472760","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008167189","display_name":"Richard F. Hobbs","orcid":"https://orcid.org/0000-0001-7976-7172","observed_orcids":["https://orcid.org/0000-0001-7976-7172"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fd Richard Hobbs","raw_affiliation_strings":["Department of Primary Care and General Practice, University of Birmingham, Birmingham. f.d.r.hobbs@bham.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Primary Care and General Practice, University of Birmingham, Birmingham. f.d.r.hobbs@bham.ac.uk","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tahir Khan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tahir Khan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5074145591","display_name":"Barbara Collins","orcid":"https://orcid.org/0000-0002-6867-6993","observed_orcids":["https://orcid.org/0000-0002-6867-6993"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Barbara Collins","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8181,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.75850663,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"55","issue":"515","first_page":"437","last_page":"443"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/doxazosin","display_name":"doxazosin","score":1.0},{"id":"https://openalex.org/keywords/bendrofluazide","display_name":"bendrofluazide","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8510000109672546},{"id":"https://openalex.org/keywords/british-south-asians","display_name":"British South Asians","score":0.9309999942779541},{"id":"https://openalex.org/keywords/glucose-metabolism","display_name":"glucose metabolism","score":0.8880000114440918},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.9829999804496765},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.9789999723434448},{"id":"https://openalex.org/keywords/total-cholesterol","display_name":"total cholesterol","score":0.7400000095367432},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.7379999756813049},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/alpha-1-adrenergic-blockers","display_name":"alpha-1 adrenergic blockers","score":0.8730000257492065},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.5590000152587891},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6880000233650208}],"concepts":[{"id":"https://openalex.org/C2777590997","wikidata":"https://www.wikidata.org/wiki/Q419939","display_name":"Doxazosin","level":3,"score":0.9831163883209229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7729045152664185},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.7474228143692017},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.6320555210113525},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5963539481163025},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5179137587547302},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.48858699202537537}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001210","descriptor_name":"Asia, Southeastern","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false},{"descriptor_ui":"D001539","descriptor_name":"Bendroflumethiazide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001539","descriptor_name":"Bendroflumethiazide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017292","descriptor_name":"Doxazosin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017292","descriptor_name":"Doxazosin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"pmh:oai:europepmc.org:263210","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1472760","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:1472760","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1472760/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Gen Pract","raw_type":"Text"},{"id":"pmid:15970067","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15970067","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of general practice : the journal of the Royal College of General Practitioners","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/de424754-f564-4a5d-9550-126d94182f3c","doi":null,"is_oa":false,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/de424754-f564-4a5d-9550-126d94182f3c","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hobbs, F, Khan, T & Collins, B 2005, 'A comparison of metabolic effects of doxazosin versus bendrofluazide in hypertensive British Asians', British Journal of General Practice, vol. 55, pp. 437-443.","raw_type":"article"},{"id":"mag:2115147648","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15970067","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:europepmc.org:263210","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1472760","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W196531891","https://openalex.org/W1597272325","https://openalex.org/W1879478146","https://openalex.org/W1966896095","https://openalex.org/W1972363683","https://openalex.org/W1978839916","https://openalex.org/W1985043745","https://openalex.org/W1986010116","https://openalex.org/W2006896821","https://openalex.org/W2009930118","https://openalex.org/W2013016047","https://openalex.org/W2015578417","https://openalex.org/W2074921868","https://openalex.org/W2092972333","https://openalex.org/W2094191671","https://openalex.org/W2117191092","https://openalex.org/W2125977155","https://openalex.org/W2135356424","https://openalex.org/W2139790172","https://openalex.org/W2146158338","https://openalex.org/W2161380795","https://openalex.org/W4301518376"],"related_works":["https://openalex.org/W2101413423","https://openalex.org/W2332593441","https://openalex.org/W1892759716","https://openalex.org/W2139374139","https://openalex.org/W2430205263","https://openalex.org/W2052582142","https://openalex.org/W2427216864","https://openalex.org/W2034718283","https://openalex.org/W2071685094"],"abstract_inverted_index":{"BACKGROUND:":[0],"People":[1],"from":[2,13],"British":[3,59,247],"South":[4,60,248],"Asian":[5,61],"communities":[6],"have":[7,33],"an":[8,111],"increased":[9,168],"risk":[10,259],"of":[11,58,114,139],"mortality":[12],"coronary":[14],"heart":[15],"disease":[16],"(CHD).":[17],"Doxazosin,":[18],"a":[19,121],"selective":[20],"alpha(1)-adrenergic":[21],"blocker,":[22],"in":[23,42,56,86,102,221,240,242,246],"addition":[24],"to":[25,32,66,77,120,255],"lowering":[26,224,243],"blood":[27,129,222],"pressure,":[28],"has":[29],"been":[30],"shown":[31],"positive":[34],"effects":[35,80,233],"on":[36,81,234],"glucose":[37,82,149,180,235],"metabolism":[38,85],"and":[39,52,83,150,165,167,177,188,202,210,237],"lipid":[40,84,238],"profiles":[41],"patients":[43,57,108],"with":[44,63,110],"hypertension.":[45],"AIM:":[46],"We":[47],"studied":[48],"doxazosin":[49,107,176],"(1-8":[50],"mg)":[51,55],"bendrofluazide":[53,73,178],"(2.5":[54],"origin":[62],"existing":[64],"mild":[65],"moderate":[67],"hypertension":[68],"(doxazosin":[69],"n":[70,74],"=":[71,75,186,192,200,208,214],"78;":[72],"82),":[76],"compare":[78],"their":[79],"this":[87],"group.":[88],"DESIGN":[89],"OF":[90],"STUDY:":[91],"A":[92],"34-week":[93],"randomised,":[94],"double-blind,":[95],"parallel-group,":[96],"multicentre":[97],"study.":[98],"SETTING:":[99],"Primary":[100],"care":[101],"the":[103,140,226],"UK.":[104],"METHOD:":[105],"All":[106],"started":[109],"initial":[112],"dose":[113],"1":[115],"mg":[116,124],"once":[117,125],"daily,":[118],"titrated":[119],"maximum":[122],"8":[123],"daily":[126],"if":[127],"diastolic":[128],"pressure":[130,223],"was":[131,135,217],">90":[132],"mmHg":[133,138],"or":[134],"not":[136],"<5":[137],"baseline":[141],"value.":[142],"The":[143],"primary":[144],"efficacy":[145],"variables":[146],"were":[147,172],"mean":[148],"total":[151,161,194],"cholesterol":[152,195],"concentrations":[153,181,236,245],"at":[154,182,196,204],"week":[155,183,189,197,205,211],"21.":[156],"RESULT:":[157],"Doxazosin":[158,230],"reduced":[159],"glucose,":[160],"cholesterol,":[162],"low-density":[163],"lipoprotein-cholesterol":[164],"triglycerides":[166,203],"high-density":[169],"lipoprotein-cholesterol.":[170],"There":[171,216],"significant":[173,219],"differences":[174],"between":[175,225],"for":[179],"21":[184,198,206],"(P":[185,191,199,207,213],"0.029)":[187],"34":[190,212],"0.015),":[193],"0.048)":[201],"0.047)":[209],"0.009).":[215],"no":[218],"difference":[220],"two":[227],"treatments.":[228],"CONCLUSION:":[229],"exhibits":[231],"beneficial":[232],"profile,":[239],"particular":[241],"triglyceride":[244],"Asians.":[249],"Whether":[250],"these":[251],"desirable":[252],"characteristics":[253],"translate":[254],"improved":[256],"overall":[257],"cardiovascular":[258],"requires":[260],"formal":[261],"evaluation.":[262]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2115147648","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
